Description: Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and dermatology, diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
Home Page: www.torrentpharma.com
Torrent House
Ahmedabad,
380009
India
Phone:
91 79 2659 9000
Officers
| Name | Title |
|---|---|
| Mr. Samir Uttamlal Mehta B.Com., MBA | Executive Chairman & MD |
| Mr. Aman Mehta | Whole-Time Director |
| Mr. Sudhir Menon CA, CWA | Chief Financial Officer |
| Mr. Chintan M. Trivedi | Company Secretary & Compliance Officer |
| Mr. Jaydip Bhatt | Vice President of Human Resource |
| Mr. Ashish Hajarnish M.Pharm | Executive Director |
| Mr. Abdullah Salam Said Al Abri | Chief Customer Service Officer |
| Mr. Sanjay Gupta | President and CEO of Torrent Pharma USA |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 56.4972 |
|---|---|
| Trailing PE: | 62.5 |
| Price-to-Book MRQ: | 15.0302 |
| Price-to-Sales TTM: | 10.0635 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 15718 |